About Aldatu Biosciences
Aldatu Biosciences is a Healthcare company based in Boston (United States) founded in 2014. Diagnostic tools for infectious diseases are developed using genotyping platforms. Aldatu Biosciences offers products and services including PANDAA Platform, SARS-CoV-2 Tests, HIV Drug Resistance Tests, and Lassa Virus Detection. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Viral. Its legal entity is Aldatu Biosciences, Inc. Its competitors include BioLife Solutions, GenScript and Fluent BioSciences; 2 of its 3 listed competitors have raised funding.
Company details
Aldatu Biosciences was founded in 2014 in Boston, United States, within the biotechnology sector. Operations center on the development of diagnostic solutions for infectious diseases, leveraging the proprietary PANDAA platforma modified qPCR protocolfor detecting HIV drug resistance in patient samples. A 1.5 million grant from the NIH was awarded in March 2015 to support test advancement. The domain aldatubio.com is utilized for online presence.
- Headquarters Boston, United States
- SectorsHealthcare
- Website aldatubio.com
- Social LinkedIn X Facebook
- Legal Name Aldatu Biosciences, Inc.
- Latest Funding Round$3M (USD), Grant
Sep 2022
- InvestorsNIH
& 2 more
Products & Services of Aldatu Biosciences
Aldatu Biosciences offers a comprehensive portfolio of products and services, including PANDAA Platform, SARS-CoV-2 Tests, HIV Drug Resistance Tests, and Lassa Virus Detection.
Adaptive PCR system for detecting viral variants in infectious diseases
Assays for detection and genotyping of SARS-CoV-2 variants
Tests for identifying drug-resistant HIV variants
PCR-based tests for detecting Lassa virus
Funding Insights of Aldatu Biosciences
- Total Rounds 8
- Last Round Grant — $3M
- First Round $1.5M
(Mar 2015)
- Investors Count 3
All 8 funding rounds of Aldatu Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Aldatu Biosciences
Aldatu Biosciences has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and SBIR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Federal innovation and scientific achievement services are provided. | 1982 | sbir.gov | Lithia Springs, United States |
Investor details for Aldatu Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aldatu Biosciences
14 people are tracked at Aldatu Biosciences (4 in leadership, 2 in board & advisors, 8 in team).
| Name | Role | Group |
|---|---|---|
Betsy Wonderly Trainor | VP Development | Leadership |
Mike Henry | Chief Business Officer | Leadership |
Larry Carrasco | Vice President Operations | Leadership |
Iain MacLeod | Co-Founder, CEO & CSO | Leadership |
William Rodriguez | Advisor | Board & advisors |
Mickey Urdea | Advisor | Board & advisors |
Ken Pierce | Lead Scientist, Assay Development | Team |
Namita Wadke | Research Associate | Team |
Maria Denaro | Scientist, Assay Assurance | Team |
John Rice | Lead Scientist, Assay Development | Team |
Ken Rice | Lead Scientist, Assay Development | Team |
Brigitte Lawhorn | Senior Research Associate | Team |
Lucy Langenberg | Research Associate | Team |
Klaire Collins | Senior Research Associate | Team |
Complete people profiles for Aldatu Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aldatu Biosciences
3 dated milestones of Aldatu Biosciences across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Aldatu Biosciences is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Grant, of $3.0M.
Competitors of Aldatu Biosciences
Aldatu Biosciences has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, GenScript and Fluent BioSciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| fluentbio.com | 2018 | Watertown, United States | $19M | Proprietary reagents for single-cell genetic analysis are developed. |
Detailed competitors of Aldatu Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aldatu Biosciences
The website of Aldatu Biosciences (aldatubio.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 7.5% vs previous month
Websites whose visitors overlap most with Aldatu Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
liliumdiagnostics.com | liliumdiagnostics.com | 100% | #7,166,163 | – | |
| sherlock.bio | 100% | 2.8K | #4,929,420 | View details | |
| dayzerodiagnostics.com | 99% | 1.4K | #5,790,285 | View details | |
| arkudatx.com | 96% | View details | |||
| dynotx.com | 72% | 14.4K | #2,089,404 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Aldatu Biosciences (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aldatu Biosciences
Complete news archive for Aldatu Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aldatu Biosciences
Aldatu Biosciences was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Aldatu Biosciences is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Aldatu Biosciences was founded in 2014 in Boston, United States, within the biotechnology sector. Operations center on the development of diagnostic solutions for infectious diseases, leveraging the proprietary PANDAA platforma modified qPCR protocolfor detecting HIV drug resistance in patient samples. A 1.5 million grant from the NIH was awarded in March 2015 to support test advancement. The domain aldatubio.com is utilized for online presence.
Aldatu Biosciences's top competitors include BioLife Solutions, GenScript and Fluent BioSciences.
Aldatu Biosciences offers PANDAA Platform, SARS-CoV-2 Tests, HIV Drug Resistance Tests, and Lassa Virus Detection.
Aldatu Biosciences operates through Aldatu Biosciences, Inc..